nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—Rosuvastatin—atherosclerosis	0.0856	0.123	CbGbCtD
Bupivacaine—CYP2C19—Simvastatin—atherosclerosis	0.0796	0.115	CbGbCtD
Bupivacaine—CYP2C19—Lovastatin—atherosclerosis	0.0779	0.112	CbGbCtD
Bupivacaine—CYP2D6—Niacin—atherosclerosis	0.0765	0.11	CbGbCtD
Bupivacaine—CYP2D6—Simvastatin—atherosclerosis	0.0605	0.0871	CbGbCtD
Bupivacaine—CYP2D6—Pravastatin—atherosclerosis	0.0592	0.0852	CbGbCtD
Bupivacaine—CYP2D6—Lovastatin—atherosclerosis	0.0592	0.0852	CbGbCtD
Bupivacaine—CYP3A4—Rosuvastatin—atherosclerosis	0.0414	0.0595	CbGbCtD
Bupivacaine—CYP3A4—Ezetimibe—atherosclerosis	0.0414	0.0595	CbGbCtD
Bupivacaine—CYP3A4—Simvastatin—atherosclerosis	0.0385	0.0554	CbGbCtD
Bupivacaine—CYP3A4—Pravastatin—atherosclerosis	0.0376	0.0542	CbGbCtD
Bupivacaine—CYP3A4—Lovastatin—atherosclerosis	0.0376	0.0542	CbGbCtD
Bupivacaine—Urinary retention—Niacin—atherosclerosis	0.0011	0.00481	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Niacin—atherosclerosis	0.00106	0.00462	CcSEcCtD
Bupivacaine—Muscular weakness—Niacin—atherosclerosis	0.00102	0.00446	CcSEcCtD
Bupivacaine—Infestation NOS—Ezetimibe—atherosclerosis	0.00102	0.00445	CcSEcCtD
Bupivacaine—Infestation—Ezetimibe—atherosclerosis	0.00102	0.00445	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00102	0.00445	CcSEcCtD
Bupivacaine—Urinary tract infection—Lovastatin—atherosclerosis	0.00101	0.00441	CcSEcCtD
Bupivacaine—Abdominal distension—Niacin—atherosclerosis	0.00101	0.0044	CcSEcCtD
Bupivacaine—Muscular weakness—Pravastatin—atherosclerosis	0.00101	0.00439	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00101	0.00439	CcSEcCtD
Bupivacaine—Dysphagia—Niacin—atherosclerosis	0.001	0.00437	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.001	0.00436	CcSEcCtD
Bupivacaine—Abdominal distension—Pravastatin—atherosclerosis	0.000995	0.00433	CcSEcCtD
Bupivacaine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000986	0.00429	CcSEcCtD
Bupivacaine—Mental disorder—Rosuvastatin—atherosclerosis	0.000967	0.00421	CcSEcCtD
Bupivacaine—Sweating increased—Pravastatin—atherosclerosis	0.000962	0.00419	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000955	0.00416	CcSEcCtD
Bupivacaine—Flatulence—Rosuvastatin—atherosclerosis	0.000946	0.00412	CcSEcCtD
Bupivacaine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000904	0.00394	CcSEcCtD
Bupivacaine—Angioedema—Rosuvastatin—atherosclerosis	0.000878	0.00382	CcSEcCtD
Bupivacaine—Flushing—Lovastatin—atherosclerosis	0.000868	0.00378	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000863	0.00376	CcSEcCtD
Bupivacaine—Sweating—Niacin—atherosclerosis	0.000858	0.00374	CcSEcCtD
Bupivacaine—Urinary tract infection—Pravastatin—atherosclerosis	0.000856	0.00373	CcSEcCtD
Bupivacaine—Flushing—Ezetimibe—atherosclerosis	0.000851	0.00371	CcSEcCtD
Bupivacaine—Chills—Lovastatin—atherosclerosis	0.000839	0.00366	CcSEcCtD
Bupivacaine—Cough—Rosuvastatin—atherosclerosis	0.000838	0.00365	CcSEcCtD
Bupivacaine—Arthralgia—Rosuvastatin—atherosclerosis	0.000818	0.00356	CcSEcCtD
Bupivacaine—Flushing—Simvastatin—atherosclerosis	0.000812	0.00354	CcSEcCtD
Bupivacaine—Mental disorder—Ezetimibe—atherosclerosis	0.000804	0.0035	CcSEcCtD
Bupivacaine—Flatulence—Lovastatin—atherosclerosis	0.000802	0.00349	CcSEcCtD
Bupivacaine—Hypoaesthesia—Niacin—atherosclerosis	0.000799	0.00348	CcSEcCtD
Bupivacaine—Erythema—Ezetimibe—atherosclerosis	0.000798	0.00348	CcSEcCtD
Bupivacaine—Malnutrition—Ezetimibe—atherosclerosis	0.000798	0.00348	CcSEcCtD
Bupivacaine—Oedema peripheral—Niacin—atherosclerosis	0.000791	0.00345	CcSEcCtD
Bupivacaine—Confusional state—Rosuvastatin—atherosclerosis	0.00079	0.00344	CcSEcCtD
Bupivacaine—Back pain—Lovastatin—atherosclerosis	0.000787	0.00343	CcSEcCtD
Bupivacaine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000787	0.00343	CcSEcCtD
Bupivacaine—Flatulence—Ezetimibe—atherosclerosis	0.000787	0.00343	CcSEcCtD
Bupivacaine—Chills—Simvastatin—atherosclerosis	0.000785	0.00342	CcSEcCtD
Bupivacaine—Muscle spasms—Lovastatin—atherosclerosis	0.000783	0.00341	CcSEcCtD
Bupivacaine—Infection—Rosuvastatin—atherosclerosis	0.000779	0.00339	CcSEcCtD
Bupivacaine—Back pain—Ezetimibe—atherosclerosis	0.000772	0.00336	CcSEcCtD
Bupivacaine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000769	0.00335	CcSEcCtD
Bupivacaine—Muscle spasms—Ezetimibe—atherosclerosis	0.000768	0.00334	CcSEcCtD
Bupivacaine—Vision blurred—Lovastatin—atherosclerosis	0.000767	0.00334	CcSEcCtD
Bupivacaine—Mental disorder—Simvastatin—atherosclerosis	0.000766	0.00334	CcSEcCtD
Bupivacaine—Tremor—Lovastatin—atherosclerosis	0.000763	0.00332	CcSEcCtD
Bupivacaine—Erythema—Simvastatin—atherosclerosis	0.000761	0.00332	CcSEcCtD
Bupivacaine—Flatulence—Simvastatin—atherosclerosis	0.00075	0.00327	CcSEcCtD
Bupivacaine—Tinnitus—Niacin—atherosclerosis	0.000749	0.00326	CcSEcCtD
Bupivacaine—Flushing—Niacin—atherosclerosis	0.000745	0.00325	CcSEcCtD
Bupivacaine—Angioedema—Lovastatin—atherosclerosis	0.000744	0.00324	CcSEcCtD
Bupivacaine—Anaemia—Ezetimibe—atherosclerosis	0.000738	0.00321	CcSEcCtD
Bupivacaine—Tinnitus—Pravastatin—atherosclerosis	0.000737	0.00321	CcSEcCtD
Bupivacaine—Flushing—Pravastatin—atherosclerosis	0.000734	0.0032	CcSEcCtD
Bupivacaine—Cardiac disorder—Pravastatin—atherosclerosis	0.000734	0.0032	CcSEcCtD
Bupivacaine—Muscle spasms—Simvastatin—atherosclerosis	0.000732	0.00319	CcSEcCtD
Bupivacaine—Angioedema—Ezetimibe—atherosclerosis	0.00073	0.00318	CcSEcCtD
Bupivacaine—Chills—Niacin—atherosclerosis	0.000721	0.00314	CcSEcCtD
Bupivacaine—Vision blurred—Simvastatin—atherosclerosis	0.000718	0.00313	CcSEcCtD
Bupivacaine—Arrhythmia—Niacin—atherosclerosis	0.000717	0.00313	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000714	0.00311	CcSEcCtD
Bupivacaine—Tremor—Simvastatin—atherosclerosis	0.000713	0.00311	CcSEcCtD
Bupivacaine—Chills—Pravastatin—atherosclerosis	0.00071	0.00309	CcSEcCtD
Bupivacaine—Insomnia—Rosuvastatin—atherosclerosis	0.000709	0.00309	CcSEcCtD
Bupivacaine—Arrhythmia—Pravastatin—atherosclerosis	0.000706	0.00308	CcSEcCtD
Bupivacaine—Palpitations—Ezetimibe—atherosclerosis	0.000706	0.00307	CcSEcCtD
Bupivacaine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000704	0.00307	CcSEcCtD
Bupivacaine—Anaemia—Simvastatin—atherosclerosis	0.000704	0.00307	CcSEcCtD
Bupivacaine—Malnutrition—Niacin—atherosclerosis	0.000699	0.00305	CcSEcCtD
Bupivacaine—Erythema—Niacin—atherosclerosis	0.000699	0.00305	CcSEcCtD
Bupivacaine—Cough—Ezetimibe—atherosclerosis	0.000697	0.00304	CcSEcCtD
Bupivacaine—Angioedema—Simvastatin—atherosclerosis	0.000696	0.00303	CcSEcCtD
Bupivacaine—Arthralgia—Lovastatin—atherosclerosis	0.000693	0.00302	CcSEcCtD
Bupivacaine—Anxiety—Lovastatin—atherosclerosis	0.000691	0.00301	CcSEcCtD
Bupivacaine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00069	0.00301	CcSEcCtD
Bupivacaine—Hypertension—Ezetimibe—atherosclerosis	0.000689	0.003	CcSEcCtD
Bupivacaine—Flatulence—Niacin—atherosclerosis	0.000689	0.003	CcSEcCtD
Bupivacaine—Tension—Niacin—atherosclerosis	0.000686	0.00299	CcSEcCtD
Bupivacaine—Arthralgia—Ezetimibe—atherosclerosis	0.00068	0.00296	CcSEcCtD
Bupivacaine—Nervousness—Niacin—atherosclerosis	0.000679	0.00296	CcSEcCtD
Bupivacaine—Flatulence—Pravastatin—atherosclerosis	0.000678	0.00296	CcSEcCtD
Bupivacaine—Tension—Pravastatin—atherosclerosis	0.000675	0.00294	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000675	0.00294	CcSEcCtD
Bupivacaine—Muscle spasms—Niacin—atherosclerosis	0.000672	0.00293	CcSEcCtD
Bupivacaine—Constipation—Rosuvastatin—atherosclerosis	0.00067	0.00292	CcSEcCtD
Bupivacaine—Pain—Rosuvastatin—atherosclerosis	0.00067	0.00292	CcSEcCtD
Bupivacaine—Confusional state—Lovastatin—atherosclerosis	0.00067	0.00292	CcSEcCtD
Bupivacaine—Nervousness—Pravastatin—atherosclerosis	0.000669	0.00291	CcSEcCtD
Bupivacaine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000664	0.00289	CcSEcCtD
Bupivacaine—Muscle spasms—Pravastatin—atherosclerosis	0.000662	0.00288	CcSEcCtD
Bupivacaine—Infection—Lovastatin—atherosclerosis	0.00066	0.00288	CcSEcCtD
Bupivacaine—Vision blurred—Niacin—atherosclerosis	0.000659	0.00287	CcSEcCtD
Bupivacaine—Confusional state—Ezetimibe—atherosclerosis	0.000657	0.00286	CcSEcCtD
Bupivacaine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000652	0.00284	CcSEcCtD
Bupivacaine—Vision blurred—Pravastatin—atherosclerosis	0.000649	0.00283	CcSEcCtD
Bupivacaine—Arthralgia—Simvastatin—atherosclerosis	0.000648	0.00282	CcSEcCtD
Bupivacaine—Infection—Ezetimibe—atherosclerosis	0.000647	0.00282	CcSEcCtD
Bupivacaine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000646	0.00281	CcSEcCtD
Bupivacaine—Anxiety—Simvastatin—atherosclerosis	0.000646	0.00281	CcSEcCtD
Bupivacaine—Tremor—Pravastatin—atherosclerosis	0.000645	0.00281	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000641	0.00279	CcSEcCtD
Bupivacaine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000639	0.00278	CcSEcCtD
Bupivacaine—Angioedema—Niacin—atherosclerosis	0.000639	0.00278	CcSEcCtD
Bupivacaine—Anaemia—Pravastatin—atherosclerosis	0.000636	0.00277	CcSEcCtD
Bupivacaine—Skin disorder—Ezetimibe—atherosclerosis	0.000633	0.00276	CcSEcCtD
Bupivacaine—Angioedema—Pravastatin—atherosclerosis	0.000629	0.00274	CcSEcCtD
Bupivacaine—Syncope—Niacin—atherosclerosis	0.000627	0.00273	CcSEcCtD
Bupivacaine—Confusional state—Simvastatin—atherosclerosis	0.000627	0.00273	CcSEcCtD
Bupivacaine—Urticaria—Rosuvastatin—atherosclerosis	0.000623	0.00271	CcSEcCtD
Bupivacaine—Oedema—Simvastatin—atherosclerosis	0.000621	0.00271	CcSEcCtD
Bupivacaine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000621	0.00271	CcSEcCtD
Bupivacaine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00062	0.0027	CcSEcCtD
Bupivacaine—Palpitations—Niacin—atherosclerosis	0.000618	0.00269	CcSEcCtD
Bupivacaine—Infection—Simvastatin—atherosclerosis	0.000617	0.00269	CcSEcCtD
Bupivacaine—Loss of consciousness—Niacin—atherosclerosis	0.000614	0.00268	CcSEcCtD
Bupivacaine—Cough—Niacin—atherosclerosis	0.00061	0.00266	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000605	0.00264	CcSEcCtD
Bupivacaine—Insomnia—Lovastatin—atherosclerosis	0.000601	0.00262	CcSEcCtD
Bupivacaine—Cough—Pravastatin—atherosclerosis	0.000601	0.00262	CcSEcCtD
Bupivacaine—Paraesthesia—Lovastatin—atherosclerosis	0.000597	0.0026	CcSEcCtD
Bupivacaine—Arthralgia—Niacin—atherosclerosis	0.000595	0.00259	CcSEcCtD
Bupivacaine—Hypertension—Pravastatin—atherosclerosis	0.000594	0.00259	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000594	0.00259	CcSEcCtD
Bupivacaine—Dyspnoea—Lovastatin—atherosclerosis	0.000592	0.00258	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000591	0.00258	CcSEcCtD
Bupivacaine—Insomnia—Ezetimibe—atherosclerosis	0.000589	0.00257	CcSEcCtD
Bupivacaine—Arthralgia—Pravastatin—atherosclerosis	0.000586	0.00255	CcSEcCtD
Bupivacaine—Paraesthesia—Ezetimibe—atherosclerosis	0.000585	0.00255	CcSEcCtD
Bupivacaine—Dyspepsia—Lovastatin—atherosclerosis	0.000585	0.00255	CcSEcCtD
Bupivacaine—Anxiety—Pravastatin—atherosclerosis	0.000584	0.00254	CcSEcCtD
Bupivacaine—Dyspnoea—Ezetimibe—atherosclerosis	0.000581	0.00253	CcSEcCtD
Bupivacaine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000578	0.00252	CcSEcCtD
Bupivacaine—Decreased appetite—Lovastatin—atherosclerosis	0.000578	0.00252	CcSEcCtD
Bupivacaine—Dyspepsia—Ezetimibe—atherosclerosis	0.000574	0.0025	CcSEcCtD
Bupivacaine—Oedema—Niacin—atherosclerosis	0.000571	0.00249	CcSEcCtD
Bupivacaine—Anaphylactic shock—Niacin—atherosclerosis	0.000571	0.00249	CcSEcCtD
Bupivacaine—Pain—Lovastatin—atherosclerosis	0.000568	0.00248	CcSEcCtD
Bupivacaine—Constipation—Lovastatin—atherosclerosis	0.000568	0.00248	CcSEcCtD
Bupivacaine—Confusional state—Pravastatin—atherosclerosis	0.000566	0.00247	CcSEcCtD
Bupivacaine—Decreased appetite—Ezetimibe—atherosclerosis	0.000566	0.00247	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000566	0.00247	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000563	0.00245	CcSEcCtD
Bupivacaine—Asthenia—Rosuvastatin—atherosclerosis	0.000562	0.00245	CcSEcCtD
Bupivacaine—Insomnia—Simvastatin—atherosclerosis	0.000562	0.00245	CcSEcCtD
Bupivacaine—Oedema—Pravastatin—atherosclerosis	0.000562	0.00245	CcSEcCtD
Bupivacaine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000562	0.00245	CcSEcCtD
Bupivacaine—Shock—Niacin—atherosclerosis	0.000561	0.00245	CcSEcCtD
Bupivacaine—Infection—Pravastatin—atherosclerosis	0.000558	0.00243	CcSEcCtD
Bupivacaine—Paraesthesia—Simvastatin—atherosclerosis	0.000558	0.00243	CcSEcCtD
Bupivacaine—Pain—Ezetimibe—atherosclerosis	0.000557	0.00243	CcSEcCtD
Bupivacaine—Constipation—Ezetimibe—atherosclerosis	0.000557	0.00243	CcSEcCtD
Bupivacaine—Tachycardia—Niacin—atherosclerosis	0.000557	0.00243	CcSEcCtD
Bupivacaine—Pruritus—Rosuvastatin—atherosclerosis	0.000555	0.00242	CcSEcCtD
Bupivacaine—Skin disorder—Niacin—atherosclerosis	0.000554	0.00241	CcSEcCtD
Bupivacaine—Dyspnoea—Simvastatin—atherosclerosis	0.000554	0.00241	CcSEcCtD
Bupivacaine—Hyperhidrosis—Niacin—atherosclerosis	0.000552	0.0024	CcSEcCtD
Bupivacaine—Feeling abnormal—Lovastatin—atherosclerosis	0.000547	0.00239	CcSEcCtD
Bupivacaine—Dyspepsia—Simvastatin—atherosclerosis	0.000547	0.00238	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000543	0.00237	CcSEcCtD
Bupivacaine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000543	0.00237	CcSEcCtD
Bupivacaine—Decreased appetite—Simvastatin—atherosclerosis	0.00054	0.00235	CcSEcCtD
Bupivacaine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000537	0.00234	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000536	0.00234	CcSEcCtD
Bupivacaine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000536	0.00234	CcSEcCtD
Bupivacaine—Hypotension—Niacin—atherosclerosis	0.000533	0.00232	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000533	0.00232	CcSEcCtD
Bupivacaine—Constipation—Simvastatin—atherosclerosis	0.000531	0.00232	CcSEcCtD
Bupivacaine—Pain—Simvastatin—atherosclerosis	0.000531	0.00232	CcSEcCtD
Bupivacaine—Urticaria—Lovastatin—atherosclerosis	0.000528	0.0023	CcSEcCtD
Bupivacaine—Abdominal pain—Lovastatin—atherosclerosis	0.000525	0.00229	CcSEcCtD
Bupivacaine—Body temperature increased—Lovastatin—atherosclerosis	0.000525	0.00229	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00052	0.00226	CcSEcCtD
Bupivacaine—Dizziness—Rosuvastatin—atherosclerosis	0.000518	0.00226	CcSEcCtD
Bupivacaine—Urticaria—Ezetimibe—atherosclerosis	0.000518	0.00226	CcSEcCtD
Bupivacaine—Insomnia—Niacin—atherosclerosis	0.000516	0.00225	CcSEcCtD
Bupivacaine—Abdominal pain—Ezetimibe—atherosclerosis	0.000515	0.00224	CcSEcCtD
Bupivacaine—Body temperature increased—Ezetimibe—atherosclerosis	0.000515	0.00224	CcSEcCtD
Bupivacaine—Paraesthesia—Niacin—atherosclerosis	0.000512	0.00223	CcSEcCtD
Bupivacaine—Feeling abnormal—Simvastatin—atherosclerosis	0.000512	0.00223	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000512	0.00223	CcSEcCtD
Bupivacaine—Dyspnoea—Niacin—atherosclerosis	0.000509	0.00222	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000508	0.00221	CcSEcCtD
Bupivacaine—Insomnia—Pravastatin—atherosclerosis	0.000508	0.00221	CcSEcCtD
Bupivacaine—Somnolence—Niacin—atherosclerosis	0.000507	0.00221	CcSEcCtD
Bupivacaine—Paraesthesia—Pravastatin—atherosclerosis	0.000504	0.0022	CcSEcCtD
Bupivacaine—Dyspepsia—Niacin—atherosclerosis	0.000502	0.00219	CcSEcCtD
Bupivacaine—Dyspnoea—Pravastatin—atherosclerosis	0.000501	0.00218	CcSEcCtD
Bupivacaine—Decreased appetite—Niacin—atherosclerosis	0.000496	0.00216	CcSEcCtD
Bupivacaine—Dyspepsia—Pravastatin—atherosclerosis	0.000495	0.00215	CcSEcCtD
Bupivacaine—Urticaria—Simvastatin—atherosclerosis	0.000494	0.00215	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000493	0.00215	CcSEcCtD
Bupivacaine—Body temperature increased—Simvastatin—atherosclerosis	0.000491	0.00214	CcSEcCtD
Bupivacaine—Abdominal pain—Simvastatin—atherosclerosis	0.000491	0.00214	CcSEcCtD
Bupivacaine—Headache—Rosuvastatin—atherosclerosis	0.000491	0.00214	CcSEcCtD
Bupivacaine—Hypersensitivity—Lovastatin—atherosclerosis	0.000489	0.00213	CcSEcCtD
Bupivacaine—Decreased appetite—Pravastatin—atherosclerosis	0.000488	0.00213	CcSEcCtD
Bupivacaine—Pain—Niacin—atherosclerosis	0.000488	0.00213	CcSEcCtD
Bupivacaine—Pain—Pravastatin—atherosclerosis	0.00048	0.00209	CcSEcCtD
Bupivacaine—Constipation—Pravastatin—atherosclerosis	0.00048	0.00209	CcSEcCtD
Bupivacaine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00048	0.00209	CcSEcCtD
Bupivacaine—Asthenia—Lovastatin—atherosclerosis	0.000477	0.00208	CcSEcCtD
Bupivacaine—Pruritus—Lovastatin—atherosclerosis	0.00047	0.00205	CcSEcCtD
Bupivacaine—Asthenia—Ezetimibe—atherosclerosis	0.000468	0.00204	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Niacin—atherosclerosis	0.000467	0.00203	CcSEcCtD
Bupivacaine—Nausea—Rosuvastatin—atherosclerosis	0.000466	0.00203	CcSEcCtD
Bupivacaine—Feeling abnormal—Pravastatin—atherosclerosis	0.000463	0.00202	CcSEcCtD
Bupivacaine—Pruritus—Ezetimibe—atherosclerosis	0.000461	0.00201	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000459	0.002	CcSEcCtD
Bupivacaine—Hypersensitivity—Simvastatin—atherosclerosis	0.000458	0.00199	CcSEcCtD
Bupivacaine—Diarrhoea—Lovastatin—atherosclerosis	0.000455	0.00198	CcSEcCtD
Bupivacaine—Urticaria—Niacin—atherosclerosis	0.000453	0.00197	CcSEcCtD
Bupivacaine—Abdominal pain—Niacin—atherosclerosis	0.000451	0.00197	CcSEcCtD
Bupivacaine—Body temperature increased—Niacin—atherosclerosis	0.000451	0.00197	CcSEcCtD
Bupivacaine—Urticaria—Pravastatin—atherosclerosis	0.000446	0.00194	CcSEcCtD
Bupivacaine—Asthenia—Simvastatin—atherosclerosis	0.000446	0.00194	CcSEcCtD
Bupivacaine—Diarrhoea—Ezetimibe—atherosclerosis	0.000446	0.00194	CcSEcCtD
Bupivacaine—Abdominal pain—Pravastatin—atherosclerosis	0.000444	0.00193	CcSEcCtD
Bupivacaine—Body temperature increased—Pravastatin—atherosclerosis	0.000444	0.00193	CcSEcCtD
Bupivacaine—Pruritus—Simvastatin—atherosclerosis	0.00044	0.00192	CcSEcCtD
Bupivacaine—Dizziness—Lovastatin—atherosclerosis	0.000439	0.00191	CcSEcCtD
Bupivacaine—Dizziness—Ezetimibe—atherosclerosis	0.000431	0.00188	CcSEcCtD
Bupivacaine—Diarrhoea—Simvastatin—atherosclerosis	0.000425	0.00185	CcSEcCtD
Bupivacaine—Vomiting—Lovastatin—atherosclerosis	0.000422	0.00184	CcSEcCtD
Bupivacaine—Hypersensitivity—Niacin—atherosclerosis	0.00042	0.00183	CcSEcCtD
Bupivacaine—Headache—Lovastatin—atherosclerosis	0.000416	0.00181	CcSEcCtD
Bupivacaine—Vomiting—Ezetimibe—atherosclerosis	0.000414	0.0018	CcSEcCtD
Bupivacaine—Hypersensitivity—Pravastatin—atherosclerosis	0.000414	0.0018	CcSEcCtD
Bupivacaine—Dizziness—Simvastatin—atherosclerosis	0.000411	0.00179	CcSEcCtD
Bupivacaine—Asthenia—Niacin—atherosclerosis	0.000409	0.00178	CcSEcCtD
Bupivacaine—Headache—Ezetimibe—atherosclerosis	0.000408	0.00178	CcSEcCtD
Bupivacaine—Pruritus—Niacin—atherosclerosis	0.000404	0.00176	CcSEcCtD
Bupivacaine—Asthenia—Pravastatin—atherosclerosis	0.000403	0.00176	CcSEcCtD
Bupivacaine—Pruritus—Pravastatin—atherosclerosis	0.000397	0.00173	CcSEcCtD
Bupivacaine—Vomiting—Simvastatin—atherosclerosis	0.000395	0.00172	CcSEcCtD
Bupivacaine—Nausea—Lovastatin—atherosclerosis	0.000395	0.00172	CcSEcCtD
Bupivacaine—Diarrhoea—Niacin—atherosclerosis	0.00039	0.0017	CcSEcCtD
Bupivacaine—Headache—Simvastatin—atherosclerosis	0.000389	0.0017	CcSEcCtD
Bupivacaine—Nausea—Ezetimibe—atherosclerosis	0.000387	0.00169	CcSEcCtD
Bupivacaine—Diarrhoea—Pravastatin—atherosclerosis	0.000384	0.00167	CcSEcCtD
Bupivacaine—Dizziness—Niacin—atherosclerosis	0.000377	0.00164	CcSEcCtD
Bupivacaine—Dizziness—Pravastatin—atherosclerosis	0.000372	0.00162	CcSEcCtD
Bupivacaine—Nausea—Simvastatin—atherosclerosis	0.000369	0.00161	CcSEcCtD
Bupivacaine—Vomiting—Niacin—atherosclerosis	0.000363	0.00158	CcSEcCtD
Bupivacaine—Headache—Niacin—atherosclerosis	0.000357	0.00156	CcSEcCtD
Bupivacaine—Vomiting—Pravastatin—atherosclerosis	0.000357	0.00156	CcSEcCtD
Bupivacaine—Headache—Pravastatin—atherosclerosis	0.000352	0.00153	CcSEcCtD
Bupivacaine—Nausea—Niacin—atherosclerosis	0.000339	0.00148	CcSEcCtD
Bupivacaine—Nausea—Pravastatin—atherosclerosis	0.000334	0.00145	CcSEcCtD
Bupivacaine—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	4.04e-05	0.000534	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SPP1—atherosclerosis	4.01e-05	0.000531	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL8—atherosclerosis	4e-05	0.000529	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.95e-05	0.000522	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.94e-05	0.000521	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.89e-05	0.000514	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.89e-05	0.000514	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—AKT1—atherosclerosis	3.88e-05	0.000513	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLTP—atherosclerosis	3.8e-05	0.000502	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—AKT1—atherosclerosis	3.74e-05	0.000495	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PDGFB—atherosclerosis	3.71e-05	0.000491	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AGT—atherosclerosis	3.63e-05	0.00048	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LEP—atherosclerosis	3.55e-05	0.00047	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APOE—atherosclerosis	3.55e-05	0.00047	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CAV1—atherosclerosis	3.52e-05	0.000465	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.52e-05	0.000465	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APOA1—atherosclerosis	3.51e-05	0.000464	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.51e-05	0.000464	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.5e-05	0.000462	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.48e-05	0.00046	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.4e-05	0.000449	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ESR1—atherosclerosis	3.39e-05	0.000449	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—F2—atherosclerosis	3.35e-05	0.000443	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCG1—atherosclerosis	3.34e-05	0.000442	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LTA4H—atherosclerosis	3.29e-05	0.000435	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG8—atherosclerosis	3.29e-05	0.000435	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.25e-05	0.00043	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CG—atherosclerosis	3.21e-05	0.000424	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—FABP4—atherosclerosis	3.14e-05	0.000415	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LCAT—atherosclerosis	3.14e-05	0.000415	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.12e-05	0.000412	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOA4—atherosclerosis	3.08e-05	0.000408	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCG1—atherosclerosis	3.07e-05	0.000406	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—MAPK3—atherosclerosis	3.07e-05	0.000406	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.07e-05	0.000406	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—INS—atherosclerosis	3.04e-05	0.000401	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP7A1—atherosclerosis	3.03e-05	0.0004	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCL2—atherosclerosis	2.99e-05	0.000395	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF1—atherosclerosis	2.94e-05	0.000388	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.93e-05	0.000388	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.89e-05	0.000382	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.89e-05	0.000382	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.89e-05	0.000382	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.84e-05	0.000375	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.8e-05	0.00037	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SERPINE1—atherosclerosis	2.79e-05	0.000369	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.79e-05	0.000368	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.76e-05	0.000364	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.74e-05	0.000362	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.69e-05	0.000356	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOS3—atherosclerosis	2.66e-05	0.000352	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.65e-05	0.000351	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOA2—atherosclerosis	2.65e-05	0.000351	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.65e-05	0.000351	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.65e-05	0.000351	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.62e-05	0.000347	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.62e-05	0.000346	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.6e-05	0.000344	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.57e-05	0.00034	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.54e-05	0.000336	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.54e-05	0.000336	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LPA—atherosclerosis	2.53e-05	0.000335	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—BGN—atherosclerosis	2.45e-05	0.000324	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—FABP4—atherosclerosis	2.45e-05	0.000324	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LCAT—atherosclerosis	2.45e-05	0.000324	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.44e-05	0.000323	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.44e-05	0.000323	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.44e-05	0.000323	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.44e-05	0.000323	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.43e-05	0.000322	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOA5—atherosclerosis	2.43e-05	0.000321	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.41e-05	0.000319	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA4—atherosclerosis	2.4e-05	0.000318	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL8—atherosclerosis	2.36e-05	0.000312	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	2.36e-05	0.000312	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.36e-05	0.000312	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.34e-05	0.000309	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LPA—atherosclerosis	2.33e-05	0.000308	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.31e-05	0.000305	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.29e-05	0.000303	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.28e-05	0.000302	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AKT1—atherosclerosis	2.28e-05	0.000302	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.26e-05	0.000298	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—BGN—atherosclerosis	2.26e-05	0.000298	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.25e-05	0.000297	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—atherosclerosis	2.25e-05	0.000297	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOA5—atherosclerosis	2.23e-05	0.000295	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	2.18e-05	0.000288	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.15e-05	0.000284	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.15e-05	0.000284	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—atherosclerosis	2.14e-05	0.000282	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NFKB1—atherosclerosis	2.11e-05	0.000279	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.1e-05	0.000277	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.08e-05	0.000276	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK8—atherosclerosis	2.08e-05	0.000275	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.08e-05	0.000274	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—atherosclerosis	2.07e-05	0.000274	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA2—atherosclerosis	2.07e-05	0.000273	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	2.07e-05	0.000273	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALOX15—atherosclerosis	2.07e-05	0.000273	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	2.07e-05	0.000273	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG5—atherosclerosis	2.04e-05	0.00027	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.04e-05	0.00027	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.02e-05	0.000268	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.01e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LIPC—atherosclerosis	2.01e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.01e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOC3—atherosclerosis	2e-05	0.000264	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.99e-05	0.000263	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPA—atherosclerosis	1.97e-05	0.000261	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CETP—atherosclerosis	1.94e-05	0.000257	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—atherosclerosis	1.92e-05	0.000254	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—BGN—atherosclerosis	1.91e-05	0.000253	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—atherosclerosis	1.9e-05	0.000251	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.9e-05	0.000251	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.89e-05	0.00025	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.89e-05	0.00025	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.89e-05	0.00025	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.86e-05	0.000246	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.86e-05	0.000246	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.85e-05	0.000245	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.85e-05	0.000245	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.84e-05	0.000243	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.84e-05	0.000243	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.83e-05	0.000242	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.82e-05	0.000241	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.82e-05	0.000241	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK3—atherosclerosis	1.81e-05	0.00024	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.81e-05	0.000239	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.8e-05	0.000238	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CETP—atherosclerosis	1.78e-05	0.000236	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.78e-05	0.000236	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.78e-05	0.000235	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—atherosclerosis	1.76e-05	0.000233	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.76e-05	0.000233	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.75e-05	0.000232	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.71e-05	0.000226	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.68e-05	0.000223	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.62e-05	0.000215	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.61e-05	0.000213	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.6e-05	0.000211	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.6e-05	0.000211	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.6e-05	0.000211	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.6e-05	0.000211	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.58e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.58e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.58e-05	0.000208	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.57e-05	0.000207	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.57e-05	0.000207	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.56e-05	0.000207	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.56e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.55e-05	0.000205	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPA—atherosclerosis	1.52e-05	0.000201	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CETP—atherosclerosis	1.51e-05	0.0002	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—BGN—atherosclerosis	1.47e-05	0.000195	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.46e-05	0.000193	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.45e-05	0.000191	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.44e-05	0.00019	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.41e-05	0.000186	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.41e-05	0.000186	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.37e-05	0.000181	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.36e-05	0.000179	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.34e-05	0.000177	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—atherosclerosis	1.33e-05	0.000175	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOB—atherosclerosis	1.29e-05	0.00017	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.25e-05	0.000165	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.23e-05	0.000163	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.23e-05	0.000163	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LPL—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—atherosclerosis	1.22e-05	0.000162	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.22e-05	0.000161	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.22e-05	0.000161	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.21e-05	0.00016	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.2e-05	0.000159	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.2e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.19e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOB—atherosclerosis	1.18e-05	0.000156	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CETP—atherosclerosis	1.17e-05	0.000154	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CD36—atherosclerosis	1.17e-05	0.000154	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.15e-05	0.000152	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LPL—atherosclerosis	1.13e-05	0.000149	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.12e-05	0.000148	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.1e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARA—atherosclerosis	1.08e-05	0.000143	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CD36—atherosclerosis	1.07e-05	0.000142	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.06e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AGT—atherosclerosis	1.05e-05	0.000139	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.05e-05	0.000138	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOE—atherosclerosis	1.03e-05	0.000136	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CAV1—atherosclerosis	1.02e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOA1—atherosclerosis	1.02e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.02e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOB—atherosclerosis	1e-05	0.000132	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARA—atherosclerosis	9.97e-06	0.000132	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—atherosclerosis	9.74e-06	0.000129	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AGT—atherosclerosis	9.66e-06	0.000128	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPL—atherosclerosis	9.56e-06	0.000126	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOE—atherosclerosis	9.46e-06	0.000125	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.41e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CAV1—atherosclerosis	9.38e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOA1—atherosclerosis	9.35e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX1—atherosclerosis	9.33e-06	0.000123	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	9.29e-06	0.000123	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CD36—atherosclerosis	9.09e-06	0.00012	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—atherosclerosis	8.96e-06	0.000118	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—INS—atherosclerosis	8.79e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—atherosclerosis	8.61e-06	0.000114	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.54e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARA—atherosclerosis	8.45e-06	0.000112	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—atherosclerosis	8.24e-06	0.000109	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AGT—atherosclerosis	8.18e-06	0.000108	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—INS—atherosclerosis	8.08e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMOX1—atherosclerosis	8.07e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALB—atherosclerosis	8.06e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOE—atherosclerosis	8.02e-06	0.000106	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CAV1—atherosclerosis	7.94e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA1—atherosclerosis	7.92e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOB—atherosclerosis	7.73e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NOS3—atherosclerosis	7.71e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.52e-06	9.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALB—atherosclerosis	7.41e-06	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPL—atherosclerosis	7.38e-06	9.76e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	7.23e-06	9.57e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX1—atherosclerosis	7.2e-06	9.52e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NOS3—atherosclerosis	7.09e-06	9.37e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—atherosclerosis	7.05e-06	9.32e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CD36—atherosclerosis	7.01e-06	9.27e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—atherosclerosis	6.98e-06	9.23e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—INS—atherosclerosis	6.85e-06	9.06e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.65e-06	8.79e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARA—atherosclerosis	6.52e-06	8.62e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.48e-06	8.57e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AGT—atherosclerosis	6.31e-06	8.35e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALB—atherosclerosis	6.28e-06	8.3e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOE—atherosclerosis	6.19e-06	8.18e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CAV1—atherosclerosis	6.13e-06	8.11e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA1—atherosclerosis	6.12e-06	8.09e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NOS3—atherosclerosis	6.01e-06	7.94e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.58e-06	7.38e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—atherosclerosis	5.49e-06	7.26e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—atherosclerosis	5.39e-06	7.13e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—INS—atherosclerosis	5.29e-06	6.99e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALB—atherosclerosis	4.85e-06	6.41e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.63e-06	6.13e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.24e-06	5.61e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—atherosclerosis	3.54e-06	4.69e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—atherosclerosis	3.26e-06	4.31e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—atherosclerosis	2.76e-06	3.65e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—atherosclerosis	2.13e-06	2.82e-05	CbGpPWpGaD
